|
NIH-BMGF--CEPI epidemic preparedness working group
|
Committee, Work group, Advisory group, or Task Force
|
ASPR, BARDA
|
ARPA-H, FIC, NCATS, NIAID
|
Working group meets quarterly to discuss collaboration, communication, and coordination on epidemic preparedness programs supported by each entity. 10 sub working groups tackle specific issues in more depth, including preparedness vaccines, antivirals, and pathogen and immune sequencing.
|
|
NIH-CMS Opioid Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
NIDA
|
Working group.
|
|
NIH-DOE Bioimaging Working Group
|
Meeting/ Workshop
|
Not Reported
|
NIBIB, NIGMS
|
Department of Energy (DOE) Offices of Basic Energy Sciences and Biological and Environmental Research, and NIH’s NIBIB and NIGMS, are working together to raise awareness within the biomedical research community of existing DOE- and NIH-supported bioimaging capabilities and identify the gaps in capabilities that must be addressed to support current and future research needs. A new NIH-DOE Bioimaging Working Group comprising subject matter experts from DOE Office of Science (SC), NIBIB, and NIGMS completed a series of public webinars in the spring of 2020 that provided the community with information on existing techniques available at both NIH and SC facilities and centers, including for data analysis, management, and knowledge. SC and NIH have jointly released a Request for Information (RFI) to gather input from the academic, clinical, and industrial communities on strategies to advance the utility of existing bioimaging technologies and technologies that need to be created to meet community needs. These webinars, and the input from the RFI, will support further discussion on perceived gaps in capabilities and how they can be addressed through interagency cooperation.
|
|
NIH-DOE Research Collaboration Workshop
|
Meeting/ Workshop
|
Not Reported
|
NCI, NIBIB
|
Workshop series designed to bring areas of research related to NIH and DOE to the fore.
|
|
NIH-FDA Interagency Clinical Outcome Assessments Working Group (ICOAWG)
|
Committee, Work group, Advisory group, or Task Force
|
FDA, FDA
|
NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, NLM, OD/DPCPSI, OD/DPCPSI/SGMRO, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP
|
The Interagency Clinical Outcome Assessments Working Group (ICOA WG) works to foster the development, evaluation, and qualification of Clinical Outcomes Assessments (COAs) for use in both medical product development and clinical research. Leveraging the unique strengths, knowledge, and resources at both the US Food and Drug Administration (FDA) and the National Institutes of Health (NIH), the objectives of the ICOA WG are: (1) To increase communication between the relevant groups at FDA and the many separate efforts at NIH to advance measurement science by exchanging information about specific COA projects of common interest, thereby improving the knowledge base for COA development; (2) To clarify and disseminate information about the regulatory processes for evaluation of medical product development tools; (3) To foster appropriate interagency scientific efforts to generate evidence toward the development and potential qualification of novel COAs; and (4) To leverage public and private efforts toward consensus and standards development in this area. The ICOA WG is composed of representatives and selected senior staff of each agency
|
|
NIH-FDA Medical Device Research Interest Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA, CMS
|
NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NINR, NLM, OD/DPCPSI/ORIP
|
MDRIG meets quarterly to share information and ideas on supporting research throughout the device development pipeline. Recent topics of interest included clinical innovation and translation efforts, artificial intelligence and machine learning in imaging, digital twins, and early feasibility supplements for the Small Business Innovation Research (SBIR) grantees that would facilitate grantee Food and Drug Administration (FDA) meetings and communication in the formative years to increase appropriate planning during the development of their technologies toward eventual FDA approval. Recently, a successful pilot program was launched through collaboration between the NCI and FDA. Scalability to other institutes was discussed. Supported by NIBIB, MDRIG continues to meet four times per year. In 2018, NIBIB hosted a trans-NIH workshop on gadolinium retention in patients after magnetic resonance imaging. Collaborators included the extramural medical imaging community. A subsequent widely referenced white paper identified gaps in knowledge and future areas for research. This workshop included FDA participation.
|
|
NIH-NSF Ecology and Evolution of Infectious Diseases Program
|
Research Initiative
|
Not Reported
|
FIC, NIAID, NIGMS
|
The Fogarty International Center (FIC), the National Institute of Allergy and Infectious Diseases (NIAID) and NIGMS of the National Institutes of Health (NIH), the United States Department of Agriculture (USDA), and the National Science Foundation (NSF) will continue this multi-year collaboration that supports research on the ecological, evolutionary, organismal, and social drivers that influence the transmission dynamics of infectious diseases. NIGMS is interested in applications that address the evolution of hosts, pathogens and their interactions as well as basic biology and population genetics of hosts and pathogens as they relate to disease transmission and prevention.
|
|
NIH-VA-DoD Pain Management Collaboratory
|
Research Initiative
|
Not Reported
|
NCCIH, NIAAA, NIAMS, NICHD, NIDA, NINDS, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/DPCPSI/ORWH
|
The PMC is addressing a critical gap between science and practice in pain management. Despite growing evidence of the efficacy and effectiveness of nonpharmacological approaches for pain management, no large scale, pragmatic effectiveness studies have been conducted that can inform clinical practice. Our purpose is to develop, support, and enact the implementation of large-scale, pragmatic clinical research in Military and Veteran healthcare delivery organizations that studies nonpharmacological approaches to pain management in innovative and integrative models of pain care delivery. Our mission to improve the capacity, tools, and skills available to health care providers to provide timely, equitable and cost-effective integrated, patient-centered, multimodal and interdisciplinary pain care that incorporates evidence-based nonpharmacological approaches to pain management while reducing the reliance on opioid and other potentially harmful medications and invasive procedures. The Pain Management Collaboratory is comprised of 11 pragmatic clinical trials that are studying nonpharmacological approaches for the management of pain and common co-occurring conditions in Military and Veterans healthcare systems and are supported by a central Coordinating Center (PMC3). The lead funding organizations of the PMC and PMC3 include the National Institutes of Health (NIH) (led by the National Center for Complementary and Integrative Health (NCCIH), plus 7 additional offices) the Department of Defense (DOD), and the Department of Veterans Affairs (VA). https://painmanagementcollaboratory.org/
|
|
NIH/BARDA Antimicrobial Resistance (AMR) Diagnostic Challenge Working Group
|
Research Initiative
|
ASPR, CDC, FDA
|
NIAID
|
The Working Group designed, launched, and managed the largest USG Challenge competition of $20M through each of the three stages during the 5 years of the competition. The goal was to support the development of novel, innovative, rapid, point-of-need diagnostic in vitro assays to improve antibiotic stewardship and decrease the rapidly expanding AMR pandemic.
|
|
NIH/DOE Medical Applications of Nuclear Science Workshop
|
Meeting/ Workshop
|
Not Reported
|
NCI, NIBIB
|
On July 12-13, 2021 a workshop entitled Advancing Medical Care through Discovery in the Physical Sciences, expressly aimed at developing critical collaborations for synergistic advancement between the Department of Energy Office of Science (DOESC) and the National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) and National Cancer Institute (NCI), with an overarching goal to enhance the mission, expand the scope, and optimize the resources of all. Working groups within the workshop were dedicated to identifying cross-cutting challenges and opportunities in the overlap of both agencies’ objectives, with two-hour sessions covering the state-of-the-art in detectors, magnetics, isotopes, electronics, data processing, radiotherapy devices, and data science. These scientific foci of mutual interest served as junctions to identify significant opportunities for cardinal cooperative efforts. The DOE/NIH relationship was noted to be broad, long-standing, and successful both for critical science and technology development and also in the training of the current and future scientific workforce. The meeting facilitated a condensation of topics expected to offer the optimal utilization of resources and to drive high-value breakthroughs for the country. The overall consensus of the meeting attendees was that DOE and NIH share large areas of mission space, currently work together in some areas, and have common areas of aligned interest, but would benefit from more formally linking together to generate additional “force-multiplied” science via coordinated research grant funding mechanisms and through frequent dialog such as this workshop to help teams develop collaborations and new areas of research. In all, there was profuse and strong enthusiasm for establishing paradigms and mechanisms that facilitate increased interaction of the medical and physical science communities, with a level of funding sufficient to achieve critical mass to result in advanced technology and patient care. Synergistic collaboration can leverage state-of-the-art technology for medical applications, and spur the development of new technology of interest to both the medical and physical sciences. Substantial prospects exist also for new discoveries within both communities working in collaboration. Many areas exist in both agencies’ spaces where collaboration would achieve tangible mission benefits. The organization committee is currently planning a follow-up meeting as a first next step in the agencies taking positive steps toward leveraging and creating programs of mutual focus and benefit. A paper describing this workshop has been recently published: : The United States Department of Energy and National Institutes of Health Collaboration: Medical Care Advances via Discovery in Physical Sciences. A jointly-sponsored DOE/NIH workshop "Advancing Medical Care through Discovery in the Physical Sciences: Radiation Detection" will be held in March of 2023. The series is to be a forum for discussion of capabilities, challenges and emerging technologies of interest to both the medical and physical scientific communities. The first workshop aimed broadly at enhancing an on-going dialogue of shared information for synergistic advancements. While maintaining the latter dialogue and search for synergy, this second workshop focuses on Radiation Detection.
|